Connection

Haiming Wei to Humans

This is a "connection" page, showing publications Haiming Wei has written about Humans.
Connection Strength

0.096
  1. IL-6 modulation for COVID-19: the right patients at the right time? J Immunother Cancer. 2021 04; 9(4).
    View in: PubMed
    Score: 0.008
  2. Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm. Cell Mol Immunol. 2021 05; 18(5):1305-1307.
    View in: PubMed
    Score: 0.007
  3. Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status. J Autoimmun. 2021 03; 118:102596.
    View in: PubMed
    Score: 0.007
  4. Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients. Proc Natl Acad Sci U S A. 2020 12 08; 117(49):30898-30899.
    View in: PubMed
    Score: 0.007
  5. Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention. Proc Natl Acad Sci U S A. 2020 12 01; 117(48):30027-30028.
    View in: PubMed
    Score: 0.007
  6. Tocilizumab is recommended for the treatment of severe COVID-19. EBioMedicine. 2020 11; 61:103045.
    View in: PubMed
    Score: 0.007
  7. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A. 2020 05 19; 117(20):10970-10975.
    View in: PubMed
    Score: 0.007
  8. Why tocilizumab could be an effective treatment for severe COVID-19? J Transl Med. 2020 04 14; 18(1):164.
    View in: PubMed
    Score: 0.007
  9. Natural Killer Cells in the Lungs. Front Immunol. 2019; 10:1416.
    View in: PubMed
    Score: 0.007
  10. Natural Killer Cells Promote Fetal Development through the Secretion of Growth-Promoting Factors. Immunity. 2017 12 19; 47(6):1100-1113.e6.
    View in: PubMed
    Score: 0.006
  11. Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial. Front Med. 2021 Jun; 15(3):486-494.
    View in: PubMed
    Score: 0.002
  12. Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm. Nat Commun. 2020 08 06; 11(1):3924.
    View in: PubMed
    Score: 0.002
  13. The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response. J Immunother Cancer. 2020 05; 8(1).
    View in: PubMed
    Score: 0.002
  14. Accumulation of Tumor-Infiltrating CD49a+ NK Cells Correlates with Poor Prognosis for Human Hepatocellular Carcinoma. Cancer Immunol Res. 2019 09; 7(9):1535-1546.
    View in: PubMed
    Score: 0.002
  15. Spatial distribution of IL4 controls iNKT cell-DC crosstalk in tumors. Cell Mol Immunol. 2020 05; 17(5):496-506.
    View in: PubMed
    Score: 0.002
  16. Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma. Hepatology. 2019 07; 70(1):168-183.
    View in: PubMed
    Score: 0.002
  17. Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma. EBioMedicine. 2019 Feb; 40:422-431.
    View in: PubMed
    Score: 0.002
  18. Activation of TLR Signaling in Sensitization-Recruited Inflammatory Monocytes Attenuates OVA-Induced Allergic Asthma. Front Immunol. 2018; 9:2591.
    View in: PubMed
    Score: 0.002
  19. Rare primary malignant mixed Müllerian tumor of the mediastinum: A case report. Medicine (Baltimore). 2018 Oct; 97(42):e12903.
    View in: PubMed
    Score: 0.002
  20. Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity. Nat Immunol. 2018 07; 19(7):723-732.
    View in: PubMed
    Score: 0.002
  21. Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion. Nat Commun. 2018 03 28; 9(1):1241.
    View in: PubMed
    Score: 0.002
  22. The differential organogenesis and functionality of two liver-draining lymph nodes in mice. J Autoimmun. 2017 Nov; 84:109-121.
    View in: PubMed
    Score: 0.001
  23. Involvement of NK Cells in IL-28B-Mediated Immunity against Influenza Virus Infection. J Immunol. 2017 08 01; 199(3):1012-1020.
    View in: PubMed
    Score: 0.001
  24. Chronic Alcohol Consumption Promotes Diethylnitrosamine-Induced Hepatocarcinogenesis via Immune Disturbances. Sci Rep. 2017 05 31; 7(1):2567.
    View in: PubMed
    Score: 0.001
  25. High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity. Cell Mol Immunol. 2007 Oct; 4(5):377-82.
    View in: PubMed
    Score: 0.001
  26. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice. BMC Cancer. 2007 Aug 04; 7:149.
    View in: PubMed
    Score: 0.001
  27. mRNA secondary structure at start AUG codon is a key limiting factor for human protein expression in Escherichia coli. Biochem Biophys Res Commun. 2006 Oct 13; 349(1):69-78.
    View in: PubMed
    Score: 0.001
  28. Involvement of interaction between Fractalkine and CX3CR1 in cytotoxicity of natural killer cells against tumor cells. Oncol Rep. 2006 Feb; 15(2):485-8.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.